[Defense mechanisms of the macro-organism in bacteriuria in chronic pyelonephritis].
In the course of 4 years we isolated 193 E. coli strains of 55 patients with chronic pyelonephritis. In patients with obstructive chronic pyelonephritis the mean value of the immunofluorescence titre (in the serum) to the E. coli strain excreted in the urine as well as the total complement were significantly increased, the serum lysozyme was significantly lower than in patients with non-obstructive chronic pyelonephritis. A relation to the activity of the disease was existing only in the non-obstructive chronic pyelonephritis, where in the active stage the total complement was significantly decreased, the complement factors C3 and C4 as well as the urine lysozyme were significantly increased in comparison to the inactive stage. 94.64% of all immunofluorescence titres obtained to the homologous strain in the patients' serum were above the border of the normal area of 1:40. A relation between level of the titre and activity of the disease could not be established. No significant differences could be proved between the titres taken to serum-sensitive and serum-resistant strains. In 32.73% of the patients we observed disturbances of the serum bactericidia against the homologous serum-sensitive E. coli urine strain at one or several points. They fall to equal shares to patients with obstructive and non-obstructive chronic pyelonephritis and were found at 66.67% in the active stage of the two forms of the disease. In patients with and without disturbances of bactericidia no significant differences in the total complement, in the complement factors C3 and C4, the C3-activator, the serum lysozyme and the immunofluorescence titres could be proved.
D000917:Antibody Formation; D001437:Bacteriuria / Q000276:immunology*; D001770:Blood Bactericidal Activity; D002908:Chronic Disease; D003165:Complement System Proteins / Q000378:metabolism; D004926:Escherichia coli / Q000276:immunology; D004927:Escherichia coli Infections / Q000276:immunology*; D005455:Fluorescent Antibody Technique; D006801:Humans; D007121:Immunocompetence; D009113:Muramidase / Q000378:metabolism; D011704:Pyelonephritis / Q000276:immunology*
D003165:Complement System Proteins; D009113:Muramidase
Abwehrmechanismen des Makroorganismus zum Zeitpunkt der Bakteriurie bei chronischer Pyelonephritis.